Sequans Communications S.A. — Form 6-K Summary
Business context and reporting period
Sequans Communications S.A., a French foreign private issuer, furnished this Form 6-K for September 2026. The filing reports a New York Stock Exchange continued-listing deficiency notice received on September 14, 2026, and publicly announced on September 23, 2026.
Financial and trading metrics
- The NYSE determined that Sequans was not in compliance with Section 802.01B of the NYSE Listed Company Manual.
- The deficiency arose because Sequans had an average global market capitalization below $50 million over a consecutive 30-trading-day period and, at the same time, stockholders’ equity below $50 million.
- The filing does not provide clear values for revenue, profit, cash flow, margins, debt, cash, liquidity, or the precise stockholders’ equity balance.
Material changes versus the prior comparable period
The filing does not present comparative operating or financial results. The material development is the new NYSE market-capitalization and stockholders’ equity deficiency notice.
Outlook, contingencies, and unusual items
- The notice does not immediately delist Sequans’ ADSs from the NYSE.
- Sequans has notified the NYSE of its intention to regain compliance and is developing a plan addressing the minimum global market capitalization requirement.
- The company has 90 days from receipt of the notice to submit a business plan showing definitive actions intended to restore compliance within nine months of receipt of the notice.
- The NYSE will determine within 45 days after receiving the plan whether Sequans has reasonably demonstrated an ability to regain compliance during the nine-month cure period.
- If the plan is accepted, the ADSs may remain listed and traded during the cure period, subject to compliance with other NYSE standards and continued NYSE review.
- The ADSs will continue trading under the symbol “SQNS,” with the added “.BC” designation indicating below-compliance status.
- Failure to regain compliance could result in suspension or delisting from the NYSE; the filing does not state that delisting is currently scheduled.
Most important facts for investors to verify
- The company’s current stockholders’ equity and global market capitalization.
- The business plan submitted to the NYSE and whether the NYSE accepts it.
- Progress toward compliance during the nine-month cure period and any subsequent NYSE determinations.
- Whether the “.BC” designation affects trading, liquidity, investor eligibility, or financing access.
- Any related financing, capital-raising, restructuring, or other actions that could affect shareholders.